|
1
|
ApSimon HT, Reef H, Phadke RV and Popovic
EA: A population-based study of brain arteriovenous malformation:
long-term treatment outcomes. Stroke. 33:2794–2800. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Crawford PM, West CR, Chadwick DW and Shaw
MD: Arteriovenous malformations of the brain: natural history in
unoperated patients. J Neurol Neurosurg Psychiatry. 49:1–10. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fults D and Kelly DL Jr: Natural history
of arteriovenous malformations of the brain: a clinical study.
Neurosurgery. 15:658–662. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Martin NA and Vinters HV: Arteriovenous
malformations. Neurovascular Surgery. Carter LP, Spetzler RF and
Hamilton MG: McGraw-Hill; New York: pp. 875–903. 1994
|
|
5
|
Chen Y, Pawlikowska L, Yao JS, et al:
Interleukin-6 involvement in brain arteriovenous malformations. Ann
Neurol. 59:72–80. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Okazaki S, Furukado S, Abe Y, et al:
Association of inflammatory markers and carotid intima-media
thickness with the risk of cardiovascular events in high-risk
patients. Cerebrovasc Dis. 30:180–187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen Y, Zhu W, Bollen AW, et al: Evidence
of inflammatory cell involvement in brain arteriovenous
malformations. Neurosurgery. 62:1340–1350. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fishman D, Faulds G, Jeffery R, et al: The
effect of novel polymorphisms in the interleukin-6 (IL-6) gene on
IL-6 transcription and plasma IL-6 levels, and an association with
systemic-onset juvenile chronic arthritis. J Clin Invest.
102:1369–1376. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feiler S, Plesnila N, Thal SC, et al:
Contribution of matrix metalloproteinase-9 to cerebral edema and
functional outcome following experimental subarachnoid hemorrhage.
Cerebrovasc Dis. 32:289–295. 2011. View Article : Google Scholar
|
|
10
|
Loftus IM, Naylor AR, Goodall S, et al:
Increased matrix metalloproteinase-9 activity in unstable carotid
plaques. A potential role in acute plaque disruption. Stroke.
31:40–47. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chyatte D and Lewis I: Gelatinase activity
and the occurrence of cerebral aneurysms. Stroke. 28:799–804. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sandalcioglu IE, Asgari S, Wende D, et al:
Proliferation activity is significantly elevated in partially
embolized cerebral arteriovenous malformations. Cerebrovasc Dis.
30:396–401. 2010. View Article : Google Scholar
|
|
13
|
Choi EJ, Walker EJ, Shen F, et al: Minimal
homozygous endothelial deletion of Eng with VEGF stimulation is
sufficient to cause cerebrovascular dysplasia in the adult mouse.
Cerebrovasc Dis. 33:540–547. 2012. View Article : Google Scholar
|
|
14
|
Terry CF, Loukaci V and Green FR:
Cooperative influence of genetic polymorphisms on interleukin 6
transcriptional regulation. J Biol Chem. 275:18138–18144. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rundek T, Elkind MS, Pittman J, et al:
Carotid intima-media thickness is associated with allelic variants
of stromelysin-1, interleukin-6, and hepatic lipase genes: the
Northern Manhattan Prospective Cohort Study. Stroke. 33:1420–1423.
2002. View Article : Google Scholar
|
|
16
|
Jones KG, Brull DJ, Brown LC, et al:
Interleukin-6 (IL-6) and the prognosis of abdominal aortic
aneurysms. Circulation. 103:2260–2265. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brull DJ, Leeson CP, Montgomery HE, et al:
The effect of the Interleukin-6-174G>C promoter gene
polymorphism on endothelial function in healthy volunteers. Eur J
Clin Invest. 32:153–157. 2002.
|
|
18
|
Acalovschi D, Wiest T, Hartmann M, et al:
Multiple levels of regulation of the interleukin-6 system in
stroke. Stroke. 34:1864–1869. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hernández-Rodríguez J, Segarra M,
Vilardell C, et al: Elevated production of interleukin-6 is
associated with a lower incidence of disease-related ischemic
events in patients with giant-cell arteritis: angiogenic activity
of interleukin-6 as a potential protective mechanism. Circulation.
107:2428–2434. 2003.
|
|
20
|
Hashimoto T, Lawton MT, Wen G, et al: Gene
microarray analysis of human brain arteriovenous malformations.
Neurosurgery. 54:410–425. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aoki Y, Jaffe ES, Chang Y, et al:
Angiogenesis and hematopoiesis induced by Kaposi’s
sarcoma-associated herpesvirus-encoded interleukin-6. Blood.
93:4034–4043. 1999.PubMed/NCBI
|
|
22
|
Gaudino M, Andreotti F, Zamparelli R, et
al: The-174G/C interleukin-6 polymorphism influences postoperative
interleukin-6 levels and postoperative atrial fibrillation. Is
atrial fibrillation an inflammatory complication? Circulation.
108(Suppl 1): II195–II199. 2003. View Article : Google Scholar
|
|
23
|
Pola R, Flex A, Gaetani E, et al:
Synergistic effect of -174G/C polymorphism of the interleukin-6
gene promoter and 469 E/K polymorphism of the intercellular
adhesion molecule-1 gene in Italian patients with history of
ischemic stroke. Stroke. 34:881–885. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Flex A, Gaetani E, Pola R, et al: The -174
G/C polymorphism of the interleukin-6 gene promoter is associated
with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg.
24:264–268. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sternlicht MD and Werb Z: How matrix
metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol.
17:463–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brinckerhoff CE and Matrisian LM: Matrix
metalloproteinases: a tail of a frog that became a prince. Nat Rev
Mol Cell Biol. 3:207–214. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Y, Pawlikowska L, Yao JS, et al:
Interleukin-6 involvement in brain arteriovenous malformations. Ann
Neurol. 59:72–80. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hashimoto T, Wu Y, Lawton MT, et al:
Coexpression of angiogenic factors in brain arteriovenous
malformations. Neurosurgery. 56:1058–1065. 2005.PubMed/NCBI
|
|
29
|
Achrol AS, Pawlikowska L, McCulloch CE, et
al: Tumor necrosis factor-alpha-238G>A promoter polymorphism is
associated with increased risk of new hemorrhage in the natural
course of patients with brain arteriovenous malformations. Stroke.
37:231–234. 2006.
|
|
30
|
Kim H, Hysi PG, Pawlikowska L, et al:
Common variants in interleukin-1-Beta gene are associated with
intracranial hemorrhage and susceptibility to brain arteriovenous
malformation. Cerebrovasc Dis. 27:176–182. 2009. View Article : Google Scholar : PubMed/NCBI
|
